QIAGEN Global Oncohematology Summit 2023 – Improving patients’ lives through testing and research

Sept. 6, 2023
Free, CME/CPD-accredited event covers therapeutic advancements, measurable residual disease, future IVDR landscape, and patient perspectives on testing benefits.

QIAGEN will host the Global Oncohematology Summit 2023, held on September 13 and 14, under the theme “I Can: Improving Patients’ Lives Through Oncohematology Testing and Research”. The virtual event unites experts and patients from around the globe to discuss the latest advances and challenges in oncohematology testing, blood cancer clinical care, and research, focusing on improving patient outcomes. Emphasizing the utmost importance of patients’ perspectives, the summit will feature their testimonies, bringing their voices and considerations to the forefront of the discussion.

The QIAGEN Global Oncohematology Summit 2023, which is expected to gather over 500 participants from across the world, is a free, educational virtual event that is CME and CPD-accredited. Event highlights include a diverse range of topics such as the latest blood cancer patient therapies management, expert views on CAR-T cell therapy and other breakthroughs, advocate and patient perspectives, new insights into testing and monitoring blood cancer and a European diagnostic laboratory’s perspective on their IVDR strategy.

To join the QIAGEN Global Oncohematology Summit on September 13 and 14, please register here.

QIAGEN release